These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24897982)

  • 1. Tobacco smoking: options for helping smokers to quit.
    Zwar NA; Mendelsohn CP; Richmond RL
    Aust Fam Physician; 2014 Jun; 43(6):348-54. PubMed ID: 24897982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of nicotine replacement therapy and stop-smoking medicines in a national sample of Aboriginal and Torres Strait Islander smokers and ex-smokers.
    Thomas DP; Briggs VL; Couzos S; Panaretto KS; van der Sterren AE; Stevens M; Borland R
    Med J Aust; 2015 Jun; 202(10):S78-84. PubMed ID: 26017263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Real-world' effectiveness of smoking cessation treatments: a population study.
    Kotz D; Brown J; West R
    Addiction; 2014 Mar; 109(3):491-9. PubMed ID: 24372901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey.
    Kasza KA; Hyland AJ; Borland R; McNeill AD; Bansal-Travers M; Fix BV; Hammond D; Fong GT; Cummings KM
    Addiction; 2013 Jan; 108(1):193-202. PubMed ID: 22891869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current approaches to pharmacotherapy for smoking cessation.
    Hudmon KS; Corelli RL; Prokhorov AV
    Ther Adv Respir Dis; 2010 Feb; 4(1):35-47. PubMed ID: 20056740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-nicotinic therapies for smoking cessation.
    Siu EC; Tyndale RF
    Annu Rev Pharmacol Toxicol; 2007; 47():541-64. PubMed ID: 17209799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies to help a smoker who is struggling to quit.
    Rigotti NA
    JAMA; 2012 Oct; 308(15):1573-80. PubMed ID: 23073954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.
    Gonzales D; Jorenby DE; Brandon TH; Arteaga C; Lee TC
    Addiction; 2010 Nov; 105(11):2002-13. PubMed ID: 20819082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
    Doggrell SA
    Expert Opin Pharmacother; 2007 Dec; 8(17):2903-15. PubMed ID: 18001252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.
    Le Houezec J; Aubin HJ
    Expert Opin Pharmacother; 2013 Oct; 14(14):1959-67. PubMed ID: 23978314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacist "toolbox" for smoking cessation: a review of methods, medicines, and novel means to help patients along the path of smoking reduction to smoking cessation.
    Wynn WP; Stroman RT; Almgren MM; Clark KJ
    J Pharm Pract; 2012 Dec; 25(6):591-9. PubMed ID: 23222855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist.
    Tonstad S
    J Cardiovasc Nurs; 2006; 21(6):433-6. PubMed ID: 17293731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking cessation.
    Rennard SI; Daughton DM
    Clin Chest Med; 2014 Mar; 35(1):165-76. PubMed ID: 24507844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varenicline: a first-line treatment option for smoking cessation.
    Garrison GD; Dugan SE
    Clin Ther; 2009 Mar; 31(3):463-91. PubMed ID: 19393839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.